| Carbocisteine | hsa00040 | Pentose and glucuronate interconversions | 2.33E-04 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | |
| Carbocisteine | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Carbocisteine | hsa00100 | Steroid biosynthesis | 4.70E-02 | 1 | P35610 | SOAT1 | More | |
| Carbocisteine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
| Carbocisteine | hsa00500 | Starch and sucrose metabolism | 1.13E-03 | 3 | O43451, P46976, P35557 | MGAM, GYG1, GCK | More | |
| Carbocisteine | hsa00512 | Mucin type O-glycan biosynthesis | 1.22E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | |
| Carbocisteine | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 4.70E-02 | 1 | P35557 | GCK | More | |
| Carbocisteine | hsa00561 | Glycerolipid metabolism | 2.62E-02 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | |
| Carbocisteine | hsa00564 | Glycerophospholipid metabolism | 1.97E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | |
| Carbocisteine | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Carbocisteine | hsa00730 | Thiamine metabolism | 1.75E-04 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | |
| Carbocisteine | hsa00770 | Pantothenate and CoA biosynthesis | 3.90E-04 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | |
| Carbocisteine | hsa00790 | Folate biosynthesis | 2.02E-02 | 1 | P15121 | AKR1B1 | More | |
| Carbocisteine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 4.00E-02 | 1 | P09211 | GSTP1 | More | |
| Carbocisteine | hsa00983 | Drug metabolism - other enzymes | 1.63E-02 | 2 | P20839, Q16772 | IMPDH1, GSTA3 | More | |
| Carbocisteine | hsa01100 | Metabolic pathways | 2.59E-02 | 11 | P35790, Q16772, P30041, P20839, O94777, P15121, O95861, P14550, Q9UHK6, Q86VZ5, Q9NVH6 | CHKA, GSTA3, PRDX6, IMPDH1, DPM2, AKR1B1, BPNT1, AKR1A1, AMACR, SGMS1, TMLHE | More | |
| Carbocisteine | hsa01240 | Biosynthesis of cofactors | 3.34E-02 | 3 | P05186, Q9Y6K8, O75911 | ALPL, AK5, DHRS3 | More | |
| Carbocisteine | hsa01523 | Antifolate resistance | 3.80E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | |
| Carbocisteine | hsa02010 | ABC transporters | 2.17E-03 | 3 | P45844, P08183, Q8IZY2 | ABCG1, ABCB1, ABCA7 | More | |
| Carbocisteine | hsa03010 | Ribosome | 3.93E-04 | 7 | P40429, P46777, Q07020, P27635, P50914, P05386, P62249 | RPL13A, RPL5, RPL18, RPL10, RPL14, RPLP1, RPS16 | More | |
| Carbocisteine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
| Carbocisteine | hsa04080 | Neuroactive ligand-receptor interaction | 2.60E-02 | 2 | P00734, Q96G91 | F2, P2RY11 | More | |
| Carbocisteine | hsa04110 | Cell cycle | 6.80E-03 | 6 | P06493, O75293, P30304, P33981, P42773, P01106 | CDK1, GADD45B, CDC25A, TTK, CDKN2C, MYC | More | |
| Carbocisteine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
| Carbocisteine | hsa04217 | Necroptosis | 2.34E-02 | 4 | P01375, P48023, Q14765, Q99878 | TNF, FASLG, STAT4, H2AC14 | More | |
| Carbocisteine | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | |
| Carbocisteine | hsa04610 | Complement and coagulation cascades | 4.11E-08 | 3 | P00734, P0C0L4, P05107 | F2, C4A, ITGB2 | More | |
| Carbocisteine | hsa04613 | Neutrophil extracellular trap formation | 4.20E-02 | 5 | P04908, Q93077, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | |
| Carbocisteine | hsa04622 | RIG-I-like receptor signaling pathway | 1.36E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | |
| Carbocisteine | hsa04640 | Hematopoietic cell lineage | 4.13E-03 | 7 | P08514, P21926, P14778, P07766, P01730, P09564, P13765 | ITGA2B, CD9, IL1R1, CD3E, CD4, CD7, HLA-DOB | More | |
| Carbocisteine | hsa04659 | Th17 cell differentiation | 2.73E-02 | 4 | Q16539, P01730, P13765, P14778 | MAPK14, CD4, HLA-DOB, IL1R1 | More | |
| Carbocisteine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | |
| Carbocisteine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
| Carbocisteine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | |
| Carbocisteine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Carbocisteine | hsa04950 | Maturity onset diabetes of the young | 4.70E-02 | 1 | P35557 | GCK | More | |
| Carbocisteine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Carbocisteine | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Carbocisteine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | |
| Carbocisteine | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | |
| Carbocisteine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | |
| Carbocisteine | hsa05133 | Pertussis | 8.35E-05 | 3 | P05107, P10145, P0C0L4 | ITGB2, IL8, C4A | More | |
| Carbocisteine | hsa05143 | African trypanosomiasis | 4.74E-05 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | |
| Carbocisteine | hsa05144 | Malaria | 5.01E-05 | 4 | P69905, P68871, P05107, P10145 | HBA2, HBB, ITGB2, IL8 | More | |
| Carbocisteine | hsa05150 | Staphylococcus aureus infection | 3.50E-02 | 2 | P0C0L4, P05107 | C4A, ITGB2 | More | |
| Carbocisteine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
| Carbocisteine | hsa05171 | Coronavirus disease - COVID-19 | 3.87E-04 | 5 | P62249, P40429, P27635, Q07020, P05386 | RPS16, RPL13A, RPL10, RPL18, RPLP1 | More | |
| Carbocisteine | hsa05204 | Chemical carcinogenesis | 4.00E-02 | 1 | P09211 | GSTP1 | More | |
| Carbocisteine | hsa05216 | Thyroid cancer | 3.80E-02 | 2 | P01106, O75293 | MYC, GADD45B | More | |
| Carbocisteine | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | |
| Carbocisteine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.09E-02 | 4 | P07766, P06239, Q9HC35, P01730 | CD3E, LCK, EML4, CD4 | More | |
| Carbocisteine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Carbocisteine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
| Carbocisteine | hsa05340 | Primary immunodeficiency | 5.76E-05 | 5 | P01730, P11912, Q8WV28, P07766, P06239 | CD4, CD79A, BLNK, CD3E, LCK | More | |
| Carbocisteine | hsa05410 | Hypertrophic cardiomyopathy | 2.60E-02 | 2 | P26012, P09493 | ITGB8, TPM1 | More | |
| Carbocisteine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Carbocisteine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | |
